CJC-1295 & Ipamorelin is a synergistic peptide research blend combining a GHRH analog with a selective GH secretagogue. CJC-1295 extends the duration of growth hormone-releasing hormone signaling while Ipamorelin selectively stimulates GH release via ghrelin receptor activation without significantly elevating cortisol or prolactin. Research has examined this combination for enhanced GH pulse amplitude, IGF-1 modulation, body composition effects, and anti-aging signaling in preclinical models. PeptideBull supplies this research blend at confirmed purity for authorized preclinical use. Not for human or veterinary consumption.
Research Articles
CJC-1295 DAC Research: A Long-Acting GHRH Analog
Investigate CJC-1295 DAC, a synthetic GHRH analog with prolonged action. This article delves into its research mechanism...
CJC-1295 Ipamorelin Combination: GH Research Insights
Discover the science behind the CJC-1295 Ipamorelin combination for growth hormone research. Explore potential applicati...
Ipamorelin Research: A Selective Growth Hormone Secretagogue
Delve into the scientific research surrounding Ipamorelin, a selective growth hormone secretagogue. Discover its unique...